IDEAYA Biosciences, Inc. (IDYA) Latest Filing Signal

Latest Filing: 10-K  |  Filed Feb 17, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for IDEAYA Biosciences, Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, IDEAYA Biosciences, Inc.'s filing signal turned positive.
earningsVibe SuperAnalyst™ Verdict: TURNED POSITIVE

Signal Performance — Stock Price Since Filing

30-Day Change
+5.98%
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Negative
GEMINI
Turned Positive
CLAUDE
Turned Positive
CHATGPT
Continuing Positive

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does IDEAYA Biosciences, Inc. actually do?
Answer:
IDEAYA Biosciences is a precision medicine oncology company focused on discovering, developing, and commercializing targeted therapies for cancer. The company leverages expertise in small-molecule drug discovery, structural biology, and bioinformatics, integrating these with translational biomarker capabilities to create potentially first-in-class treatments. Its pipeline includes product candidates for synthetic lethality and antibody-drug conjugates (ADCs) targeting molecularly defined solid tumors. IDEAYA's clinical strategy emphasizes evaluating product candidates in rational combinations and earlier disease settings to maximize patient impact. The company has established strategic collaborations with leading pharmaceutical companies to advance its development programs.
Question:
What are IDEAYA Biosciences, Inc.'s revenue drivers?
Answer:
Revenue is primarily driven by collaboration agreements, including upfront payments, milestone payments, and royalties from licensing agreements with pharmaceutical partners for the development and commercialization of its product candidates.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required